Saturday 17 October 2026
Export LFMD’s income statement to Excel — free account
LifeMD, Inc.
LFMD Healthcare Health Information Services
LifeMD, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $194.1 million, up 25.3% from fiscal 2024. In the quarter to June 2026, revenue fell 3.55%, EPS fell 166.7% and free cash flow fell 247.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
2.34
0.12
−4.88%
Follow LFMD
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 8 | 6 | 4 |
+8 more TTM periods Free account |
| (69.60%) | 34.95% | 144.18% | 913.95% | ||
| (4.35%) | 3.56% | 15.35% | (17.07%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
116.73% | 58.54% | 88.55% | 90.99% | |
Average Days of Receivables |
21.44 | 18.61 | 17.50 | 20.23 | |
Free Cash Flow per Share |
(0.38) | (0.08) | (0.03) | 0.07 | |
Free Cash Flow |
(18.28) | (3.91) | (1.24) | 3.08 | |
Capital Expenditures |
(8.37) | (9.57) | (9.52) | (9.55) | |
| Other line items | |||||
Cash ROIC |
(55.20%) | (7.91%) | (2.07%) | 11.35% | |
Accounts Receivable Turnover |
20.62 | 19.29 | 19.64 | 21.82 | |
Accounts Payable Turnover |
1.13 | 1.37 | 2.21 | 1.65 | |
Inventory Turnover |
7.72 | 8.30 | 9.95 | 9.60 | |
Average Days of Payables |
276.72 | 309.89 | 186.34 | 244.56 | |
Days of Inventory on Hand |
45.05 | 45.47 | 36.53 | 42.93 | |
Tax Rate |
0.00 | 0.00 | 0.06 | 0.09 | |
Research and Development Expense of Revenue |
3.78% | 3.77% | 3.79% | 3.77% | |
Selling, General and Administrative Expense of Revenue |
82.23% | 78.85% | 74.21% | 70.86% | |
Share Based Compensation of Revenue |
4.22% | 4.86% | 5.41% | 6.56% | |
Interest Coverage |
— | (10.25) | (3.79) | (4.72) | |
Operating CF/Net income |
3.41 | 2.21 | 0.74 | (1.07) | |
Depreciation/Fixed assets |
3.88 | 3.43 | 3.09 | 3.12 | |
Capex/Depreciation |
(1.06) | (1.24) | (1.26) | (1.19) | |
Revenue per Share |
4.01 | 4.08 | 4.30 | 3.61 | |
Operating CF per Share |
(0.21) | 0.12 | 0.18 | 0.27 | |
Capex per Share |
(0.18) | (0.20) | (0.21) | (0.21) | |
Capex to Sales |
0.04 | 0.05 | 0.05 | 0.06 |
Columns are period end dates